NICA in the News
Read more about NICA in our latest press mentions.
Would you like to mention us or include NICA resources in your upcoming article or write-up? Please email our Communications Director, Cristina Threlkeld, with your inquiry. firstname.lastname@example.org
National Public Radio, npr.org
“Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients”
This article describes an active 80-year-old woman’s experience searching for monoclonal antibody drugs to treat her case of COVID-19. The interviewer lists our COVID-19 Antibody Therapy Locator as a tool that links those in need to infusion clinics offering antibody therapies. Note: This article has been syndicated to several local NPR branches’ websites.
Yahoo Finance, finance.yahoo.com
“Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses”
This article, published January 12th, 2021, announces that the U.S. government has said it will continue to coordinate allocation of the antibody cocktail to state and territorial health departments. Our locator site is listed as a tool for patients, caregivers and healthcare providers can use to find sites with COVID-19 antibody treatments.
Ventura County Star, vcstar.com
“Experimental COVID-19 treatment aimed at keeping Ventura County residents out of hospitals”
NICA President and CEO, Brian Nyquist, is quoted in this article expressing the importance of COVID-positive patients receiving treatment in a timely manner, and the NICA COVID-19 Antibody Treatment locator is linked.
YakTriNews (Washington, KAPP/KVEW TV) yaktrinews.com
“Lower valley hospital sees success with COVID-19 antibody treatments”
This article explains how one local hospital in Sunnyside, Washington successful administered monoclonal antibodies to COVID-positive patients. Our NICA COVID-19 Antibody Treatment Locator is mentioned as a helpful resource used by patients to find treatment locations near them.
“NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression”
This article mentions that under the EUA, REGEN-COV is available throughout the U.S. and information on availability can be found through us!